Arcturus Therapeutics Holdings

Arcturus Therapeutics Holdings Inc. is a messenger RNA medicines company focused on developing therapeutics and vaccines for infectious diseases and rare disorders. The company’s core platforms include STARR, a self-amplifying mRNA technology, and LUNAR, a lipid-mediated delivery system designed to help deliver RNA medicines into the body. Its current work centers on liver and respiratory rare diseases, with programs aimed at conditions such as cystic fibrosis and ornithine transcarbamylase deficiency, alongside vaccine candidates for seasonal and pandemic influenza and COVID-19. Arcturus Therapeutics also supports drug substance and drug product manufacturing capabilities as part of its RNA medicine development and commercialization activities. Headquartered in San Diego, California, Arcturus Therapeutics Holdings Inc. plays a specialized role in the biotechnology market by advancing RNA-based approaches for both therapeutic and preventive applications.